OpGen

OpGen Capital Expenditures

The Capital Expenditures (CapEx) of OpGen (OPGN) as of Oct 19, 2026 is -4.00 USD.

Capital Expenditures

-4.00USD

Last updated:

Capital Expenditures (CapEx) of OpGen is 2025 -4.00 USD. Capital Expenditures (CapEx) of OpGen was 2024 0.00 USD. It decreases by % lower compared to the previous year.

The OpGen Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-147,767.00 USD
Jan 1, 2019
-31,826.00 USD
Jan 1, 2020
-130,354.00 USD
Jan 1, 2021
-1.98 M USD
Jan 1, 2022
-590,772.00 USD
Jan 1, 2023
-800,412.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
-4.00 USD
The OpGen Capital Expenditures history
YEARCapital ExpendituresYoY
-4.00USD—
0.00USD-100.00%
-800,412.00USD+35.49%
-590,772.00USD-70.22%
-1.98 MUSD+1,421.71%
-130,354.00USD+309.58%
-31,826.00USD-78.46%
-147,767.00USD-46.64%
-276,950.00USD+124.23%
-123,514.00USD-33.34%
-185,296.00USD+368.66%
-39,537.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

OpGen Stock analysis

What does OpGen do? OpGen Inc is a biotechnology company based in Gaithersburg, Maryland, operating within the Health Care sector. The company went public on May 5, 2015, with ticker OPGN and ISIN US68373L5057. It currently employs three people. OpGen develops molecular information solutions focused on combating infectious diseases in global healthcare settings. The company's technology involves DNA tests and bioinformatics to address antibiotic resistance, assisting healthcare providers in managing patient care decisions and monitoring the spread of multidrug-resistant microorganisms. Its solutions aim to guide clinicians with information about life-threatening infections and help manage patient outcomes. The company's website is http://opgen.com/. OpGen is engaged in creating tools to help protect the hospital biome through customized screening and surveillance. The firm markets its high-resolution DNA tests under the Acuitas trade name. The company has a global network of customers and partners. OpGen does not provide specific details on its product names beyond Acuitas, and no additional financial figures or historical data are available in the provided information. OpGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OpGen stock

Capital Expenditures (CapEx) of OpGen is -4.00 USD in 2025.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) OpGen since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s OpGen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — OpGen

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — OpGen